(Press-News.org)
Hepatic steatosis, often triggered by non-alcoholic fatty liver disease (NAFLD), is a leading cause of liver dysfunction globally, affecting approximately 30% of the population. The progression from steatosis to hepatic fibrosis, which may ultimately lead to cirrhosis, is a significant concern in liver disease management. This review highlights the critical role of solute carrier (SLC) family transporters in both hepatic steatosis and fibrosis. SLC transporters are membrane-bound proteins responsible for transporting a variety of molecules, including fatty acids, amino acids, and nucleotides, across biological membranes. The review aims to explore how these transporters influence the pathophysiological processes underlying liver diseases, focusing on their roles in lipid metabolism, hepatocyte function, and the development of fibrosis.
Role of SLC Transporters in Hepatic Steatosis
SLC transporters contribute to the development of hepatic steatosis by regulating lipid metabolism. Members of the SLC family, such as SLC2A2 (GLUT2), SLC2A4 (GLUT4), and SLC2A5 (GLUT5), are involved in glucose and fatty acid transport into liver cells, affecting processes such as de novo lipogenesis (DNL) and glucose-induced lipid accumulation. Dysregulation of glucose transporters like GLUT2 can exacerbate insulin resistance (IR) and promote lipogenesis in hepatocytes. In contrast, GLUT4's translocation to the cell membrane in response to insulin signaling influences glucose uptake, and abnormal GLUT4 activity can further contribute to steatosis, particularly in response to high-fat diets.
Mechanisms of Action and Impact on Hepatic Fibrosis
As steatosis progresses, hepatic fibrosis can develop as a result of chronic liver injury. The activation of hepatic stellate cells (HSCs), the epithelial-mesenchymal transition (EMT) of hepatocytes, and macrophage polarization are key events in this process. SLC transporters influence these cellular responses. For example, SLC1A5, a glutamine transporter, is upregulated in conditions like non-alcoholic steatohepatitis (NASH), and its inhibition can reduce HSC activation and the subsequent fibrotic response. Transporters like GLUT1, expressed by HSCs, are also implicated in fibrosis by facilitating glucose uptake in activated stellate cells, thereby promoting fibrosis via enhanced glycolysis.
SLC Transporters in Drug-Induced Liver Injury
Beyond their role in lipid metabolism, SLC transporters are also implicated in drug-induced liver injury. For instance, multidrug resistance-associated transporters are critical in mediating the hepatic response to pharmacological agents, such as statins and anti-tuberculosis drugs, which can cause drug-induced hepatic steatosis. SLC transporters regulate the uptake and efflux of these drugs, influencing their effects on liver cells and potentially contributing to hepatic dysfunction.
Conclusion
SLC transporters play pivotal roles in the development and progression of hepatic steatosis and fibrosis through their regulation of lipid and glucose metabolism, cellular responses to injury, and drug interactions. Understanding the molecular mechanisms of these transporters provides valuable insights into liver disease pathophysiology and offers potential therapeutic targets for managing NAFLD, NASH, and hepatic fibrosis. Continued research on SLC transporters, including clinical trials targeting these proteins, could lead to the development of novel therapeutic strategies for liver diseases.
Full text
https://www.xiahepublishing.com/2310-8819/JCTH-2024-00348
The study was recently published in the Journal of Clinical and Translational Hepatology.
The Journal of Clinical and Translational Hepatology (JCTH) is owned by the Second Affiliated Hospital of Chongqing Medical University and published by XIA & HE Publishing Inc. JCTH publishes high quality, peer reviewed studies in the translational and clinical human health sciences of liver diseases. JCTH has established high standards for publication of original research, which are characterized by a study’s novelty, quality, and ethical conduct in the scientific process as well as in the communication of the research findings. Each issue includes articles by leading authorities on topics in hepatology that are germane to the most current challenges in the field. Special features include reports on the latest advances in drug development and technology that are relevant to liver diseases. Regular features of JCTH also include editorials, correspondences and invited commentaries on rapidly progressing areas in hepatology. All articles published by JCTH, both solicited and unsolicited, must pass our rigorous peer review process.
Follow us on X: @xiahepublishing
Follow us on LinkedIn: Xia & He Publishing Inc.
END
Scientists have a new target to prevent cold sores after University of Virginia School of Medicine researchers discovered an unexpected way the herpes virus re-activates in the body. The finding could also have important implications for genital herpes caused by the same virus.
The discovery from UVA’s Anna Cliffe, PhD, and colleagues seems to defy common sense. She and her team found that the slumbering herpes virus will make a protein to trigger the body’s immune response as part of its escape from dormancy. You’d think this would be bad for the virus – that activating the body’s ...
Glenview, Illinois – The American College of Chest Physicians (CHEST), the PF Warriors, the Rare Disease Diversity Coalition (RDDC)—a program at the Black Woman's Health Imperative—and the National Association of Community Health Workers (NACHW) announce their collaboration to address idiopathic pulmonary fibrosis (IPF) as a chronic disease on Rare Disease Day 2025.
Together, the organizations will employ designated activities that will build a knowledge base on the current IPF landscape ...
The study, which examined 121 babies aged three to twelve months in Accra, the capital of Ghana, demonstrates a remarkable variety of language input in the early months of life. The children are regularly exposed to two to six languages. Strikingly, the number of caregivers the children have also ranges between two and six, and babies who have more adults in their daily lives who regularly take care of them also hear more different languages. In Ghana, families often live in so-called “compound buildings”, where many ...
Virginia Tech is spearheading a research coalition to reveal the untapped potential of the greater Appalachian Mountains region.
This coalition aims to accelerate the identification and characterization of unconventional critical mineral resources throughout the area. It brings together academic institutions, research laboratories, federal and state natural resource offices, and consultancies, all collaborating with the end goal of boosting regional economic growth and creating new jobs.
The research team, led by Richard Bishop, professor of practice in ...
A recent study published in Engineering delves into the behavior of reinforced concrete beams strengthened with Carbon Fiber Reinforced Polymer (CFRP) and Ultra-High-Performance Concrete (UHPC) under thermocyclic loading. This research, conducted by Ju-Hyung Kim and Yail J. Kim, aims to understand the effects of multi-hazard loading on these strengthened structures, which is crucial for the maintenance and rehabilitation of existing buildings.
Multi-hazards, such as the combination of seismic events and high temperatures, pose ...
Paul Armsworth, Distinguished Service Professor in the Department of Ecology and Evolutionary Biology at the University of Tennessee, Knoxville, has received a 2025 Southeastern Conference Faculty Achievement Award for excellence in teaching, research and service.
He and the 15 other recipients this year — one from each SEC member university — are now nominated for the SEC Professor of the Year Award, which will be announced later in the spring.
“I am thrilled to receive this recognition, but it is also very humbling to be celebrated in this ...
A recent study published in Engineering presents a groundbreaking method for comprehensively evaluating the performance of aeroengines, the crucial components powering aircraft. Authored by Shubin Si and other researchers from esteemed institutions in China, this research addresses long-standing challenges in aeroengine performance assessment.
Aeroengines are complex systems, and their performance directly impacts flight safety and efficiency. Traditional evaluation methods, such as airlines relying on single-parameter indicators like exhaust gas temperature or manufacturers conducting ...
A study led by UMass Chan researchers demonstrated that a gene therapy to correct a mutation that causes maple syrup urine disease (MSUD) prevented newborn death, normalized growth, restored coordinated expression of the affected genes and stabilized biomarkers in a calf as well as in mice.
“Simply put, we believe the gene therapy demonstrated in both animal species, especially in the cow, very well showcases the therapeutic potential for MSUD, in part because the diseased cow, without treatment, has a very similar metabolic profile as the patients,” said Dan Wang, PhD, assistant ...
Drug-induced liver injury (DILI) is a significant concern in clinical practice, arising from medications, herbs, and dietary supplements. It can manifest in different forms, including hepatocellular, cholestatic, and mixed types, each associated with specific liver enzyme abnormalities and histological injury patterns. Hepatocellular DILI is characterized by inflammation, necrosis, and apoptosis, while cholestatic DILI involves bile plug formation and bile duct paucity. Ursodeoxycholic acid (UDCA), a widely used treatment for cholestatic liver diseases, has recently been investigated for its potential therapeutic effects ...
Hepatic biliary adenofibroma (BAF) is a rare benign bile duct neoplasm that has garnered increasing attention due to its potential role as a precursor lesion for intrahepatic cholangiocarcinoma (iCCA). Although it shares histopathological features with other biliary tumors, BAF is distinct in its composition, consisting of low-grade tubuloglandular and microcystic bile duct structures embedded in a dense fibrous stroma. Despite its classification as a benign tumor, emerging case reports suggest that BAF may undergo malignant transformation. However, its rarity and limited molecular characterization contribute to diagnostic ...
